Inhibrx Inc

NASDAQ:INBX  
34.32
-0.13 (-0.38%)
5:28:58 PM EDT: $34.32 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Inhibrx Inc Stock, NASDAQ:INBX

11025 North Torrey Pines Road, Suite 200, La Jolla, California 92037
United States of America
Phone: +1.858.795.4220
Number of Employees: 172
http://www.inhibrx.com

Description

Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm�s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA.